Impact of HER2 low expression in the Oncotype DX RS in patients with operable hormone receptor positive early stage breast cancer.

Authors: Munoz-Arcos, Laura Sofia, Nicolo', Eleonora, Newman, Lisa A., Cigler, Tessa, Andreopoulou, Eleni, Moore, Anne, Donahue, Jeannine, Cristofanilli, Massimo

Source: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p575-575, 1p

Prognostic value of tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer (BC): A focus on inflammatory BC.

Authors: Nicolò, Eleonora, Munoz-Arcos, Laura Sofia, D'Amico, Paolo, Zhang, Youbin, Gerratana, Lorenzo, Manai, Marwa, Serafini, Mara Serena, Strickland, Amanda Kaylan, Davis, Andrew A., Donahue, Jeannine, Liu, Huiping, Gradishar, William John, Shah, Ami N., Curigliano, Giuseppe, Reduzzi, Carolina, Cristofanilli, Massimo

Source: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p1098-1098, 1p